Ecosystem News
-
AB2 Bio signs USD 600 million agreement with Nippon Shinyaku
AB2 Bio Ltd., developing therapies for the treatment of severe systemic hyperinflammatory diseases and conditions driven by IL-18, has entered into an option and licensing…
startupticker.ch
-
ZuriQ secures $4.2M seed funding to break quantum computing's scaling barrier
Quantum computing startup ZuriQ has today announced the closing of its $4.2 million seed funding round to commercialize a radical new architecture that will enable scaling…
startupticker.ch
-
Transmutex receives $4 million grant to enable nuclear waste transmutation
Geneva-based startup Transmutex has received more than $4.2 million from the U.S. Department of Energy Advanced Research Projects Agency-Energy as part of the NEWTON Program.…
startupticker.ch
-
Tech Tour Growth Top 50 showcases Swiss deeptech companies
Switzerland is a hub of innovation, home to numerous trailblazing startups, including six that have earned a spot in the Tech Tour Growth Top 50…
startupticker.ch
-
BioVersys to go public at SIX Swiss Exchange
BioVersys develops novel antibacterial products for serious life-threatening infections caused by multidrug-resistant bacteria. The Basel-based company plans to conduct an initial public offering on the…
startupticker.ch
-
Swiss startups strengthen presence in North America
With the establishment of their new offices in the US, Attolight, Blocksport and NewBiologix, aim to increase proximity to customers in the North American market,…
startupticker.ch
-
RhyGaze raises USD 86 million to advance gene therapy for retinal diseases
Based in Basel and Philadelphia, USA, RhyGaze has secured a Series A financing of USD 86 million to enable clinical advancements for its lead candidate,…
startupticker.ch
-
Sygnum achieves unicorn status with USD 58m growth round
Global digital asset banking group Sygnum has raised a total of USD 58 million in its oversubscribed Strategic Growth Round, giving it a post-money valuation…
startupticker.ch
-
Windward Bio launches with $200 million Series A financing round
Founded by serial entrepreneur Luca Santarelli, Windward Bio has just launched with a $200 million capital injection. These funds will accelerate clinical advancements in programs…
startupticker.ch
-
ONWARD Medical wins first commercial customers in the US
With the first commercial sale of the ARC-EX System in the US, ONWARD Medical has reached a key milestone in its journey to provide innovative…
startupticker.ch
-
Numab raises additional CHF50 million
Numab Therapeutics, a clinical stage biotechnology company focusing on multi-specific antibodies in immunology and oncology, closed an oversubscribed CHF 50 million Series C extension, bringing…
startupticker.ch
-
CeQur secures $120 million to scale diabetes management solutions
With more than 6000 patients using the injection-free insulin delivery device, CeQur Simplicity patch, Medtech company CeQur has secured fresh equity funding to further drive…
startupticker.ch